Explore

Researchers Investigate GLP-1 Drugs for Potential Anti-Aging Effects

Researchers Investigate GLP-1 Drugs for Potential Anti-Aging Effects

Scientists are exploring whether GLP-1 medications, commonly used for weight loss and diabetes, could also slow the aging process. Researchers at the University of Texas Medical Branch (UTMB) in Galveston, Texas, are conducting one of the first clinical trials to examine if tirzepatide, the active ingredient in Zepbound, impacts aging. This trial will follow adults aged 55 to 70 who qualify for weight loss treatment, studying their biological age markers, inflammation levels, cognitive function, strength, and mobility. Separately, researchers at the UC San Diego School of Medicine and Case Western Reserve University are analyzing blood from 84 adult participants with HIV and abnormal body fat buildup. Early findings from a previous study showed that after 32 weeks, participants taking semaglutide, found in Ozempic and Wegovy, exhibited changes consistent with slower aging based on DNA-based 'aging clocks.' Dr. Michael Corley, an associate professor of medicine at UCSD, noted that this initial signal warran...

Amazon Accused of Using 'Dark Money' to Oppose NYC Delivery Protection Act

Amazon Accused of Using 'Dark Money' to Oppose NYC Delivery Protection Act

Amazon is reportedly funneling $5 million to a group called Five Borough Jobs Campaign to lobby against New York City's Delivery Protection Act (Intro 518). This legislation would require Amazon to treat its delivery drivers as employees and take responsibility for its delivery operations. Critics, including the executive directors of Common Cause New York and ALIGN: The Alliance for a Greater New York, argue that Amazon is using 'dark money' tactics by hiding behind this astroturf group to create a misleading narrative that opposition to the bill comes from small businesses. The $5 million contribution from Amazon constitutes 97% of all contributions to the Five Borough Jobs Campaign in 2026, yet these funding disclosures are only made public twice a year, allowing Amazon to lobby council members and run ads without immediate transparency regarding the source of the funds. The current system allows Amazon to subcontract the risks and liabilities of last-mile delivery, leading to concerns about street safe...

Why New York Spent $100,000 on a Public Bathhouse in 1901

Why New York Spent $100,000 on a Public Bathhouse in 1901

The Rivington Street municipal bath, once a cornerstone of public health and community life in New York City, experienced a complete lifecycle from...

Inside New York City's First Publicly Funded Bathhouse

Inside New York City's First Publicly Funded Bathhouse

The Rivington Street municipal bath, New York City's first publicly funded bathhouse, was more than just a place for hygiene; it was a tangible out...

President Trump's Vaccine Executive Order and NYC Pied-à-Terre Tax Face Legal Hurdles

President Trump's Vaccine Executive Order and NYC Pied-à-Terre Tax Face Legal Hurdles

President Donald Trump recently signed an executive order addressing the childhood vaccine schedule, specifically recommending that the measles, mumps, and rubella (MMR) vaccine be administered as three separate shots rather than a single combined dose. This executive action, which was announced on August 16, 2026, is widely anticipated to face significant legal challenges and is not expected to result in an immediate, widespread impact on vaccine accessibility for parents across the nation. Dr. Elizabeth Murray, a representative from the American Academy of Pediatrics, engaged in public discussions to help navigate the potential confusion and implications arising from this executive order, emphasizing the medical community's perspective on established vaccination protocols. In a parallel development, New York City is currently dealing with a notable legal setback concerning its proposed pied-à-terre tax. A judge on Staten Island issued a temporary restraining order, which effectively halted the enforceme...

Parents Administer GLP-1 Medications to Children for Obesity and Related Health Issues

Parents Administer GLP-1 Medications to Children for Obesity and Related Health Issues

Parents in the U.S. are increasingly opting to administer GLP-1 medications, such as Wegovy and Zepbound, to their children to address obesity and associated health conditions. This trend is emerging despite the drugs traditionally being reserved for adults. For instance, Jenna Ceriani put her son on a GLP-1 after he was removed from a football league due to his weight and struggled with sleep apnea. Similarly, Angela, a mother from Pennsylvania, chose GLP-1s for her daughter who experienced compulsive thoughts about food and metabolic dysfunction. Pediatric obesity specialists like Dr. Shaista Safder of Orlando Health support this approach, viewing GLP-1s as a crucial intervention for children with comorbidities like fatty liver disease, aiming to prevent irreversible damage. Dr. Anna Trepekli, co-founder of Hey Nouri, a virtual pediatric obesity clinic, frames GLP-1s as a treatment for a medical condition rather than solely weight loss, creating an opportunity for children to develop healthier habits. Th...

Lawsuit Alleges GLP-1 Weight Loss Drugs Cause Permanent Vision Loss

Lawsuit Alleges GLP-1 Weight Loss Drugs Cause Permanent Vision Loss

A multi-district lawsuit, comprising over 130 cases, is currently before a Philadelphia judge, claiming that popular GLP-1 medications are linked to a rare and permanent form of vision loss. The lawsuit targets drug manufacturers Novo Nordisk and Eli Lilly, producers of widely prescribed medications such as Wegovy, Ozempic, Mounjaro, and Zepbound. The core of these lawsuits, including one filed in Massachusetts, revolves around non-arteritic anterior ischemic optic neuropathy (NAION), an irreversible condition often described as an eye stroke resulting from restricted blood flow. A 2024 study published in JAMA Ophthalmology by researchers at Mass Eye and Ear in Boston indicated that diabetic patients prescribed GLP-1 medications were more than four times more likely to be diagnosed with NAION, while overweight patients taking the drugs were more than seven times more likely to receive the diagnosis. Attorney Jason Goldstein, serving on the multi-district lawsuit steering committee, highlighted that NAION s...

Inside the Lower East Side Bathhouse Built to Handle 3,000 Visits a Day

Inside the Lower East Side Bathhouse Built to Handle 3,000 Visits a Day

In the bustling, densely populated Lower East Side of Manhattan at the turn of the 20th century, a significant public health initiative took shape....

Multi-District Lawsuit Alleges GLP-1 Weight Loss Drugs Cause Permanent Blindness

Multi-District Lawsuit Alleges GLP-1 Weight Loss Drugs Cause Permanent Blindness

A multi-district lawsuit, comprising over 130 cases, is currently before a Philadelphia judge, claiming that popular GLP-1 medications, including Wegovy, Ozempic, Mounjaro, and Zepbound, are linked to a rare and permanent form of vision loss known as non-arteritic anterior ischemic optic neuropathy (NAION). This irreversible condition, often described as an eye stroke, is caused by restricted blood flow. The lawsuit targets drug manufacturers Novo Nordisk and Eli Lilly. A 2024 study published in JAMA Ophthalmology by researchers at Mass Eye and Ear in Boston indicated that diabetic patients prescribed GLP-1 medications were more than four times more likely to be diagnosed with NAION, while overweight patients taking the drugs were more than seven times more likely to receive the diagnosis. Attorney Jason Goldstein, serving on the lawsuit's steering committee, highlighted that NAION strikes suddenly and without warning, leading to permanent vision loss. One plaintiff, Diane Wirth, a former nurse practitione...

Maven Clinic Launches 'Onward' Summit to Address Future of Women's and Family Health

Maven Clinic Launches 'Onward' Summit to Address Future of Women's and Family Health

Maven Clinic, identified as the world's largest virtual clinic for women and families, has announced its inaugural annual industry summit named 'Onward.' The event is scheduled for September 30 in New York City. This summit is designed to bring together benefits leaders, health plan executives, clinicians, and healthcare innovators to discuss and shape the future of women's and family health. The initiative comes at a time when employers are facing the highest projected healthcare cost increases in over 15 years, making women's and family health a rapidly evolving area of benefits strategy. The summit will feature actress, mother, and breast cancer advocate Olivia Munn as a headliner, who will share her experiences and advocate for early detection and risk assessment. Key topics for discussion include evolving fertility policy, maternity reimbursement models, the role of AI in care delivery, GLP-1s, hormone care, and measuring clinical outcomes.

Senators Warner and Kaine Champion Legislation to Aid Coal Miners Amid Surging Black Lung Cases

Senators Warner and Kaine Champion Legislation to Aid Coal Miners Amid Surging Black Lung Cases

U.S. Senators Mark Warner and Tim Kaine, both Democrats from Virginia, are actively supporting legislation aimed at assisting coal miners and their families, particularly in response to a resurgence of black lung disease cases in Appalachia. They have co-sponsored the Black Lung Benefits Improvement Act, designed to streamline the process for miners to receive financial benefits, and the Relief for Survivors of Miners Act, which seeks to provide support for surviving spouses. This legislative push comes as new research indicates that black lung disease among Appalachian coal miners has reached a nearly 50-year high, with a significant increase in cases among both experienced and younger miners. Advocates attribute this surge to inadequate enforcement of federal regulations and exposure to silica dust from deeper drilling operations. The Biden administration had proposed stricter safety standards, but these were delayed and subsequently challenged in court, with the Trump administration not defending the ru...

Jewish Watchdog Urges NYPD to Increase Presence After Manhattan Synagogue Attack

Jewish Watchdog Urges NYPD to Increase Presence After Manhattan Synagogue Attack

A Jewish security watchdog, the Community Security Initiative (CSI), is advocating for increased NYPD presence in potential hate crime hotspots following an antisemitic attack at Manhattan's Central Synagogue. On a Friday night, Larry Montes, 46, entered the synagogue's main sanctuary, disrupted the service with antisemitic slurs, struck a 63-year-old congregant, and headbutted a security personnel member while being escorted out. Montes, who has three prior arrests for robbery, was charged with multiple counts, including assault as a hate crime and disruption of a religious service. The incident occurred despite the synagogue's security team quickly defusing the situation, as Montes did not initially raise red flags upon entry. Antisemitic hate crimes in New York City have seen an 8.5% increase compared to the previous year, as of late July.